Cardiovascular–kidney–metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study
PLOS Medicine · 26.06.2025 · 22 (6) · e1004629
DOI: 10.1371/journal.pmed.1004629 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS Medicine, online erschienen am 26.06.2025. Verfasst von Min-Kuang Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, Ministry of Health and Welfare.
Abstract (Originalsprache)
Background
The American Heart Association recently issued guidelines introducing the concept of cardiovascular–kidney–metabolic (CKM) syndrome to emphasize the importance of multidisciplinary approaches to prevention, risk stratification, and treatment for these diseases. This study assessed the prevalence of CKM syndrome stages and the mortality risk associated with its components in a large Asian cohort. Methods and findings We analyzed a retrospective cohort of 515,602 participants aged ≥20 years from a health screening program conducted between 1996 and 2017 in Taiwan. We assessed the associations of all-cause mortality, cardiovascular disease (CVD) mortality, and cause-specific mortality with CKM stages and its components—hypertension, diabetes mellitus, chronic kidney disease (CKD), metabolic syndrome, and hyperlipidemia. All participants were followed for a median of 16.5 years (interquartile range: 11.5, 21.2 years). Multivariate Cox proportional hazards models, adjusted for age, sex, educational level, smoking status, alcohol drinking status, and physical activity groups, were used to calculate hazard ratios (HRs). We used Chiang’s life table method to estimate years of life lost due to each CKM component. Among all participants, 257,535 (49.9%) were female. The majority of participants ( n = 368,578 participants, (71.5%)) met criteria for CKM syndrome, with prevalence rates of 19.5%, 46.3%, 1.9%, and 3.8% for stages 1, 2, 3, and 4, respectively. CKM syndrome was associated with higher risks of all-cause mortality (HR: 1.33; 95% confidence interval, CI: 1.28, 1.39), CVD mortality (HR: 2.81; 95% CI: 2.45, 3.22), and incident end-stage kidney disease (ESKD) (HR: 10.15; 95% CI: 7.54, 13.67). Each additional CKM component was associated with a 22% increase in the risk of all-cause mortality (HR: 1.22; 95% CI: 1.21, 1.23), a 37% increase in the risk of CVD mortality (HR: 1.37; 95% CI: 1.35, 1.40) compared with those without any CKM components. In addition, each additional component reduced average life expectancy by 3 years. The population-attributable fractions of CKM syndrome were 18.7% (95% CI: 15.8, 21.7) for all-cause mortality and 55.0% (95% CI: 49.0, 60.4) for CVD mortality. We estimated that failing to include CKD in CKM syndrome could result in the missed attribution of 11% of CVD deaths. The primary limitation is that our analysis relied on baseline measurements only, without accounting for longitudinal changes.
Conclusions
In the large cohort study, the prevalence of CKM syndrome and its components were associated with risks of all-cause mortality, CVD mortality, and ESKD. These findings highlight the clinical need for integrated care within CKM health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Taipei Medical University Research Center of Urology and Kidney (TMU-RCUK), Taipei Medical University, Taipei, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Fu-Jen Catholic University Hospital, Fu-Jen Catholic University, New Taipei City, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
- Division of Emergency Medicine, Department of Emergency and Critical Care, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Department of Emergency Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Min-Kuang Tsai, Wei-Cheng Lo, Kuo-Liong Chien, Mei-Yi Wu
Förderung
- National Science and Technology Council
- Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
- Ministry of Health and Welfare
Zitieren
APA
Tsai, M. K., Kao, J. T., Wong, C. S., Liao, C. T., Lo, W. C., Chien, K. L., Wen, C. P., Wu, M. S., & Wu, M. Y. (2025). Cardiovascular–kidney–metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study. PLOS Medicine, 22(6), e1004629. https://doi.org/10.1371/journal.pmed.1004629
Vancouver
Tsai MK, Kao JT, Wong CS, Liao CT, Lo WC, Chien KL, et al. Cardiovascular–kidney–metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study. PLOS Medicine. 2025;22(6):e1004629. doi:10.1371/journal.pmed.1004629
BibTeX
@article{Tsai2025,
author = {Tsai, Min-Kuang and Kao, Juliana Tze-Wah and Wong, Chung-Shun and Liao, Chia-Te and Lo, Wei-Cheng and Chien, Kuo-Liong and Wen, Chi-Pang and Wu, Mai-Szu and Wu, Mei-Yi},
title = {Cardiovascular–kidney–metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study},
journal = {PLOS Medicine},
year = {2025},
volume = {22},
number = {6},
pages = {e1004629},
doi = {10.1371/journal.pmed.1004629}
}
EUVIMED